XVIR-210

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameXVIR-210
Drug Alias Namenano-formulated prodrug of tenofovirXVIR-210NM1TFV
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analoguesSmall molecules > Prodrug
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHepatitis B, ChronicHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExavir Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesExavir Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A